The Team
  • Anne MAGLOTT-ROTH

  • Engineers & Technicians

    Amélie WEISS

Technology platforms

High-throughput screening

Publications

Print the whole list

  • Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.

    Tacconi EM(1), Badie S(1), De Gregoriis G(1), Reislander T(1), Lai X(1), Porru M(2), Folio C(1), Moore J(3), Kopp A(4), Baguna Torres J(5), Sneddon D(5), Green M(3), Dedic S(1), Lee JW(1), Batra AS(6), Rueda OM(6), Bruna A(6), Leonetti C(2), Caldas C(6), Cornelissen B(5), Brino L(4), Ryan A(3), Biroccio A(2), Tarsounas M(1).

    EMBO Mol Med Jul 2019;11:e9982.

  • ISCA1 is essential for mitochondrial Fe4S4 biogenesis in vivo.

    Beilschmidt LK(1,)(2,)(3,)(4,)(5), Ollagnier de Choudens S(6,)(7,)(8), Fournier M(1,)(2,)(3,)(4), Sanakis I(9), Hograindleur MA(6,)(7,)(8,)(10), Clemancey M(7,)(8,)(10), Blondin G(7,)(8,)(10), Schmucker S(1,)(2,)(3,)(4,)(5), Eisenmann A(1,)(2,)(3,)(4,)(5), Weiss A(1,)(2,)(3,)(4), Koebel P(1,)(2,)(3,)(4), Messaddeq N(1,)(2,)(3,)(4), Puccio H(1,)(2,)(3,)(4,)(5), Martelli A(1,)(2,)(3,)(4,)(5).

    Nat Commun May 11, 2017;8:15124.

Imprimer Envoyer

Université de Strasbourg
INSERM
CNRS

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr